Copyright Reports & Markets. All rights reserved.

Global Biological Excipient Market Research Report 2022

Buy now

1 Biological Excipient Market Overview

  • 1.1 Product Overview and Scope of Biological Excipient
  • 1.2 Biological Excipient Segment by Type
  • 1.2.1 Global Biological Excipient Sales Growth Rate Comparison by Type (2022-2028)
  • 1.2.2 Oral
  • 1.2.3 Topical
  • 1.3 Biological Excipient Segment by Application
  • 1.3.1 Global Biological Excipient Sales Comparison by Application: (2022-2028)
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
  • 1.3.4 Others
  • 1.4 Global Biological Excipient Market Size Estimates and Forecasts
  • 1.4.1 Global Biological Excipient Revenue 2017-2028
  • 1.4.2 Global Biological Excipient Sales 2017-2028
  • 1.4.3 Biological Excipient Market Size by Region: 2017 Versus 2021 Versus 2028
  • 2 Biological Excipient Market Competition by Manufacturers

    • 2.1 Global Biological Excipient Sales Market Share by Manufacturers (2017-2022)
    • 2.2 Global Biological Excipient Revenue Market Share by Manufacturers (2017-2022)
    • 2.3 Global Biological Excipient Average Price by Manufacturers (2017-2022)
    • 2.4 Manufacturers Biological Excipient Manufacturing Sites, Area Served, Product Type
    • 2.5 Biological Excipient Market Competitive Situation and Trends
    • 2.5.1 Biological Excipient Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Biological Excipient Players Market Share by Revenue
  • 2.5.3 Global Biological Excipient Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 3 Biological Excipient Retrospective Market Scenario by Region

    • 3.1 Global Biological Excipient Retrospective Market Scenario in Sales by Region: 2017-2022
    • 3.2 Global Biological Excipient Retrospective Market Scenario in Revenue by Region: 2017-2022
    • 3.3 North America Biological Excipient Market Facts & Figures by Country
    • 3.3.1 North America Biological Excipient Sales by Country
  • 3.3.2 North America Biological Excipient Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
  • 3.4 Europe Biological Excipient Market Facts & Figures by Country
  • 3.4.1 Europe Biological Excipient Sales by Country
  • 3.4.2 Europe Biological Excipient Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
  • 3.5 Asia Pacific Biological Excipient Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Biological Excipient Sales by Region
  • 3.5.2 Asia Pacific Biological Excipient Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 China Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.6 Latin America Biological Excipient Market Facts & Figures by Country
  • 3.6.1 Latin America Biological Excipient Sales by Country
  • 3.6.2 Latin America Biological Excipient Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.6.6 Colombia
  • 3.7 Middle East and Africa Biological Excipient Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Biological Excipient Sales by Country
  • 3.7.2 Middle East and Africa Biological Excipient Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE
  • 4 Global Biological Excipient Historic Market Analysis by Type

    • 4.1 Global Biological Excipient Sales Market Share by Type (2017-2022)
    • 4.2 Global Biological Excipient Revenue Market Share by Type (2017-2022)
    • 4.3 Global Biological Excipient Price by Type (2017-2022)

    5 Global Biological Excipient Historic Market Analysis by Application

    • 5.1 Global Biological Excipient Sales Market Share by Application (2017-2022)
    • 5.2 Global Biological Excipient Revenue Market Share by Application (2017-2022)
    • 5.3 Global Biological Excipient Price by Application (2017-2022)

    6 Key Companies Profiled

    • 6.1 Ashland Inc.
    • 6.1.1 Ashland Inc. Corporation Information
  • 6.1.2 Ashland Inc. Description and Business Overview
  • 6.1.3 Ashland Inc. Biological Excipient Sales, Revenue and Gross Margin (2017-2022)
  • 6.1.4 Ashland Inc. Biological Excipient Product Portfolio
  • 6.1.5 Ashland Inc. Recent Developments/Updates
  • 6.2 BASF Corporation
  • 6.2.1 BASF Corporation Corporation Information
  • 6.2.2 BASF Corporation Description and Business Overview
  • 6.2.3 BASF Corporation Biological Excipient Sales, Revenue and Gross Margin (2017-2022)
  • 6.2.4 BASF Corporation Biological Excipient Product Portfolio
  • 6.2.5 BASF Corporation Recent Developments/Updates
  • 6.3 Colorcon Inc.
  • 6.3.1 Colorcon Inc. Corporation Information
  • 6.3.2 Colorcon Inc. Description and Business Overview
  • 6.3.3 Colorcon Inc. Biological Excipient Sales, Revenue and Gross Margin (2017-2022)
  • 6.3.4 Colorcon Inc. Biological Excipient Product Portfolio
  • 6.3.5 Colorcon Inc. Recent Developments/Updates
  • 6.4 Evonik Industries
  • 6.4.1 Evonik Industries Corporation Information
  • 6.4.2 Evonik Industries Description and Business Overview
  • 6.4.3 Evonik Industries Biological Excipient Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 Evonik Industries Biological Excipient Product Portfolio
  • 6.4.5 Evonik Industries Recent Developments/Updates
  • 6.5 FMC Corporation
  • 6.5.1 FMC Corporation Corporation Information
  • 6.5.2 FMC Corporation Description and Business Overview
  • 6.5.3 FMC Corporation Biological Excipient Sales, Revenue and Gross Margin (2017-2022)
  • 6.5.4 FMC Corporation Biological Excipient Product Portfolio
  • 6.5.5 FMC Corporation Recent Developments/Updates
  • 6.6 Roquette Frères
  • 6.6.1 Roquette Frères Corporation Information
  • 6.6.2 Roquette Frères Description and Business Overview
  • 6.6.3 Roquette Frères Biological Excipient Sales, Revenue and Gross Margin (2017-2022)
  • 6.6.4 Roquette Frères Biological Excipient Product Portfolio
  • 6.6.5 Roquette Frères Recent Developments/Updates
  • 6.7 Signet Chemical Corporation Pvt. Ltd.
  • 6.6.1 Signet Chemical Corporation Pvt. Ltd. Corporation Information
  • 6.6.2 Signet Chemical Corporation Pvt. Ltd. Description and Business Overview
  • 6.6.3 Signet Chemical Corporation Pvt. Ltd. Biological Excipient Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 Signet Chemical Corporation Pvt. Ltd. Biological Excipient Product Portfolio
  • 6.7.5 Signet Chemical Corporation Pvt. Ltd. Recent Developments/Updates
  • 6.8 The Archer Daniels Midland Company
  • 6.8.1 The Archer Daniels Midland Company Corporation Information
  • 6.8.2 The Archer Daniels Midland Company Description and Business Overview
  • 6.8.3 The Archer Daniels Midland Company Biological Excipient Sales, Revenue and Gross Margin (2017-2022)
  • 6.8.4 The Archer Daniels Midland Company Biological Excipient Product Portfolio
  • 6.8.5 The Archer Daniels Midland Company Recent Developments/Updates
  • 6.9 The Dow Chemical Company
  • 6.9.1 The Dow Chemical Company Corporation Information
  • 6.9.2 The Dow Chemical Company Description and Business Overview
  • 6.9.3 The Dow Chemical Company Biological Excipient Sales, Revenue and Gross Margin (2017-2022)
  • 6.9.4 The Dow Chemical Company Biological Excipient Product Portfolio
  • 6.9.5 The Dow Chemical Company Recent Developments/Updates
  • 6.10 Wacker Chemie AG.
  • 6.10.1 Wacker Chemie AG. Corporation Information
  • 6.10.2 Wacker Chemie AG. Description and Business Overview
  • 6.10.3 Wacker Chemie AG. Biological Excipient Sales, Revenue and Gross Margin (2017-2022)
  • 6.10.4 Wacker Chemie AG. Biological Excipient Product Portfolio
  • 6.10.5 Wacker Chemie AG. Recent Developments/Updates
  • 6.11 Merck KGaA
  • 6.11.1 Merck KGaA Corporation Information
  • 6.11.2 Merck KGaA Biological Excipient Description and Business Overview
  • 6.11.3 Merck KGaA Biological Excipient Sales, Revenue and Gross Margin (2017-2022)
  • 6.11.4 Merck KGaA Biological Excipient Product Portfolio
  • 6.11.5 Merck KGaA Recent Developments/Updates
  • 6.12 Colorcon
  • 6.12.1 Colorcon Corporation Information
  • 6.12.2 Colorcon Biological Excipient Description and Business Overview
  • 6.12.3 Colorcon Biological Excipient Sales, Revenue and Gross Margin (2017-2022)
  • 6.12.4 Colorcon Biological Excipient Product Portfolio
  • 6.12.5 Colorcon Recent Developments/Updates
  • 6.13 Associated British Foods plc
  • 6.13.1 Associated British Foods plc Corporation Information
  • 6.13.2 Associated British Foods plc Biological Excipient Description and Business Overview
  • 6.13.3 Associated British Foods plc Biological Excipient Sales, Revenue and Gross Margin (2017-2022)
  • 6.13.4 Associated British Foods plc Biological Excipient Product Portfolio
  • 6.13.5 Associated British Foods plc Recent Developments/Updates
  • 6.14 Signet Excipients Pvt. Ltd (IMCD)
  • 6.14.1 Signet Excipients Pvt. Ltd (IMCD) Corporation Information
  • 6.14.2 Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Description and Business Overview
  • 6.14.3 Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Sales, Revenue and Gross Margin (2017-2022)
  • 6.14.4 Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Product Portfolio
  • 6.14.5 Signet Excipients Pvt. Ltd (IMCD) Recent Developments/Updates
  • 6.15 Sigachi Industries Limited
  • 6.15.1 Sigachi Industries Limited Corporation Information
  • 6.15.2 Sigachi Industries Limited Biological Excipient Description and Business Overview
  • 6.15.3 Sigachi Industries Limited Biological Excipient Sales, Revenue and Gross Margin (2017-2022)
  • 6.15.4 Sigachi Industries Limited Biological Excipient Product Portfolio
  • 6.15.5 Sigachi Industries Limited Recent Developments/Updates
  • 6.16 Spectrum Chemical Manufacturing Corp.
  • 6.16.1 Spectrum Chemical Manufacturing Corp. Corporation Information
  • 6.16.2 Spectrum Chemical Manufacturing Corp. Biological Excipient Description and Business Overview
  • 6.16.3 Spectrum Chemical Manufacturing Corp. Biological Excipient Sales, Revenue and Gross Margin (2017-2022)
  • 6.16.4 Spectrum Chemical Manufacturing Corp. Biological Excipient Product Portfolio
  • 6.16.5 Spectrum Chemical Manufacturing Corp. Recent Developments/Updates
  • 6.17 IMCD
  • 6.17.1 IMCD Corporation Information
  • 6.17.2 IMCD Biological Excipient Description and Business Overview
  • 6.17.3 IMCD Biological Excipient Sales, Revenue and Gross Margin (2017-2022)
  • 6.17.4 IMCD Biological Excipient Product Portfolio
  • 6.17.5 IMCD Recent Developments/Updates
  • 6.18 Clariant
  • 6.18.1 Clariant Corporation Information
  • 6.18.2 Clariant Biological Excipient Description and Business Overview
  • 6.18.3 Clariant Biological Excipient Sales, Revenue and Gross Margin (2017-2022)
  • 6.18.4 Clariant Biological Excipient Product Portfolio
  • 6.18.5 Clariant Recent Developments/Updates
  • 7 Biological Excipient Manufacturing Cost Analysis

    • 7.1 Biological Excipient Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Biological Excipient
  • 7.4 Biological Excipient Industrial Chain Analysis
  • 8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Biological Excipient Distributors List
    • 8.3 Biological Excipient Customers

    9 Biological Excipient Market Dynamics

    • 9.1 Biological Excipient Industry Trends
    • 9.2 Biological Excipient Market Drivers
    • 9.3 Biological Excipient Market Challenges
    • 9.4 Biological Excipient Market Restraints

    10 Global Market Forecast

    • 10.1 Biological Excipient Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Biological Excipient by Type (2023-2028)
  • 10.1.2 Global Forecasted Revenue of Biological Excipient by Type (2023-2028)
  • 10.2 Biological Excipient Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Biological Excipient by Application (2023-2028)
  • 10.2.2 Global Forecasted Revenue of Biological Excipient by Application (2023-2028)
  • 10.3 Biological Excipient Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Biological Excipient by Region (2023-2028)
  • 10.3.2 Global Forecasted Revenue of Biological Excipient by Region (2023-2028)
  • 11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
    • 12.1.2 Market Size Estimation
    • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
    • 12.2.1 Secondary Sources
    • 12.2.2 Primary Sources
    • 12.3 Author List
    • Biologic excipients are compounds excluding the pharmacologically active drug component that are used in the synthesis of biologic drugs or are found in the dosage form of a finished pharmaceutical product. They help with formulation design and have a variety of functions, including boosting flow ability, improving flow ability, and increasing compressibility. The biologic excipients market is developing due to rising demand for prolonged or sustained-release formulations and increasing demand for biologic excipients. During the projected period, growing regulatory stringency regarding medication and excipient approval is expected to restrain the market's growth. Patient safety is dependent on the quality of pharmaceutical excipients throughout their life cycle. Low-quality excipients' effects, such as decreased API solubility, have enhanced the necessity of managing many parts of the excipient life cycle, such as design, production and transportation.
      Industry Insights

      Due to the COVID-19 pandemic, the global Biological Excipient market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Biological Excipient market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Biological Excipient landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

      Oral accounting for % of the Biological Excipient global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

      The global major manufacturers of Biological Excipient include Ashland Inc., BASF Corporation, Colorcon Inc., Evonik Industries, FMC Corporation, Roquette Frères, Signet Chemical Corporation Pvt. Ltd., The Archer Daniels Midland Company and The Dow Chemical Company, etc. In terms of revenue, the global 3 largest players have a % market share of Biological Excipient in 2021.

      This report focuses on Biological Excipient volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Biological Excipient market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe and China, etc.

      Key Drivers & Barriers

      High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

      Post-covid-19 Outlook

      The readers in the section will understand how the Biological Excipient market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

      Segmental Outlook

      Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

      Segment by Type

      Oral

      Topical

      Segment by Application

      Hospitals

      Clinics

      Others

      Regional Outlook

      This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

      North America

      United States

      Canada

      Europe

      Germany

      France

      U.K.

      Italy

      Russia

      Asia-Pacific

      China

      Japan

      South Korea

      India

      Australia

      China Taiwan

      Indonesia

      Thailand

      Malaysia

      Latin America

      Mexico

      Brazil

      Argentina

      Colombia

      Middle East & Africa

      Turkey

      Saudi Arabia

      UAE

      Competitive Scenario

      In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

      Ashland Inc.

      BASF Corporation

      Colorcon Inc.

      Evonik Industries

      FMC Corporation

      Roquette Frères

      Signet Chemical Corporation Pvt. Ltd.

      The Archer Daniels Midland Company

      The Dow Chemical Company

      Wacker Chemie AG.

      Merck KGaA

      Colorcon

      Associated British Foods plc

      Signet Excipients Pvt. Ltd (IMCD)

      Sigachi Industries Limited

      Spectrum Chemical Manufacturing Corp.

      IMCD

      Clariant

      Frequently Asked Questions

      Which product segment grabbed the largest share in the Biological Excipient market?

      How is the competitive scenario of the Biological Excipient market?

      Which are the key factors aiding the Biological Excipient market growth?

      Which are the prominent players in the Biological Excipient market?

      Which region holds the maximum share in the Biological Excipient market?

      What will be the CAGR of the Biological Excipient market during the forecast period?

      Which application segment emerged as the leading segment in the Biological Excipient market?

      What key trends are likely to emerge in the Biological Excipient market in the coming years?

      What will be the Biological Excipient market size by 2028?

      Which company held the largest share in the Biological Excipient market?

      Buy now